Published date: 6 January 2023

This notice was replaced on 6 January 2023

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Opportunity (published 6 January 2023)

Awarded contract - This means that the contract has been awarded to a supplier.


Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

SW1H 0EU

Value of contract

£1,083,000

Procurement reference

CF-1249400D0O000000rwimUAA

Published date

6 January 2023

Closing date

31 March 2021

Closing time

12am

Contract start date

1 April 2021

Contract end date

31 March 2022

Contract type

Supply contract

Procedure type

Negotiated procedure without prior publication (above threshold)

The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

The Department of Health and Social Care conducted a Direct Award under the Regulation 32(2)(b)(iii) of the Public Contracts Regulations 2015 (as amended) for the supply of Pulmicort Turbohaler 400 mg. The contract period expires on 31 March 2022.

More information

Previous notice about this procurement

For the supply of Pulmicort Turbohaler 400

  • Awarded contract
  • Published 6 January 2023

Attachments

Award information

Awarded date

23 February 2022

Contract start date

1 April 2021

Contract end date

31 March 2022

Total value of contract

£1,083,000

This contract was awarded to 1 supplier.

*DUPLICATE* ASTRAZENECA UK LIMITED

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA CB2 0AA

Reference

None

Supplier is SME?

No

About the buyer

Contact name

Simeon Hadebe

Address

39 Victoria Street
LONDON
SW1H 0EU
GB

Email

Simeon.Hadebe@dhsc.gov.uk